Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Antithrombin III

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Antithrombin III:

Pubmed Logo
Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation.
OBJECTIVE: Preterm labor is associated with excessive maternal thrombin...
11th November, 2009
Perinatology Research Branch, NICHD, NIH, DHHS, Bethesda, Maryland, USA. J Matern Fetal Neonatal Med. 2009 Nov;22(11):971-82.
A Simple Method for Quantitative Analysis of N-linked Glycoproteins in Hepatocellular Carcinoma Specimens.
Changes in N-liked glycan structures are related to the initiation and...
11th November, 2009
J Proteome Res. 2009 Nov 10.
DOI Direct Link
Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia.
PURPOSE: In the Anastrozole, Tamoxifen Alone or in Combination trial, the...
6th November, 2009
Authors' Affiliations: Divisions of Cancer Prevention and Genetics, Clin Cancer Res. 2009 Nov 3.
DOI Direct Link
Impact of Antithrombin III Concentrates on Portal Vein Thrombosis After Splenectomy in Patients With Liver Cirrhosis and Hypersplenism.
OBJECTIVE:: The aim of this study was to determine the role of...
30th October, 2009
From the *Department of Surgery and Science, Graduate School of Medical Ann Surg. 2009 Oct 27.
DOI Direct Link
[Denaturing high-performance liquid chromatography for screening antithrombin III gene mutation and polymorphisms in patients with cerebral venous thrombosis.]
OBJECTIVE: To identify antithrombin III (AT-III) gene mutation and...
29th October, 2009
Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Nan Fang Yi Ke Da Xue Xue Bao. 2009 Oct;29(10):1982-6.

View more research publications.

Press Releases About Antithrombin III:

BioPortfolio Logo
Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R) 20th November, 2009 Merck & Co., Inc.
WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has
Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 19th November, 2009 Dilon Diagnostics
NEWPORT NEWS, Va., Nov. 19 /PRNewswire/ -- Breast-Specific Gamma Imaging/Molecular Breast Imaging (BSGI/MBI) has been recognized and endorsed by two highly esteemed organizations for the fight against
Curemark Opens Patient Enrollment for Autism Treatment at Three More Clinical Trial Sites 19th November, 2009 Curemark LLC
RYE, N.Y., Nov. 19 /PRNewswire/ -- Curemark LLC, (www.curemark.com), a drug research and development company focused on the treatment of neurological diseases, announced that the company has begun
Delcath Systems Reports Substantial Progress 19th November, 2009 Delcath Systems, Inc.
-- Established a low cost operations facility in Queensbury, New York in which Delcath plans to locate manufacturing of its PHP System. "With the enrollment in our Phase III
Malaria Experts Call on Federal Government to Increase Support for Research and Development 18th November, 2009 The American Society of Tropical Medicine and Hygiene
WASHINGTON, Nov. 18 /PRNewswire-USNewswire/ -- While efforts to control and eliminate malaria have made great strides during the past five years, the looming specter of drug resistance heightens the

BioNews Results for Antithrombin III:

RSS Logo
BioPortfolio Logo
Pulmonary thromboembolism (Proceedings)
Thomson Veterinary Healthcare Communications:  Oct 25 2009 1:25PM Matching: antithrombin iii
Basic parameters of thrombophilia in ocular Behcet disease with posterior segment involvement
British Journal of Ophthalmology:  Oct 15 2009 1:35AM Matching: antithrombin iii

Antithrombin III Clinical Trials:

Clinical Trials Logo
Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.

Antithrombin III Patents:

USPTO Logo
US Patent No.Title
7557190 Optimized proteins that target Ep-CAM
7575930 Method for analyzing oligosaccharides from blood plasma
7576071 Antithrombotic compound
7576098 Heterocyclic compounds as inhibitors of factor VIIa
7576132 Arginine silicate inositol complex and use thereof

View more patents.

Companies working in the area of Antithrombin III from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Diagnostica & Analys Service AB

Haemophilia caused by Factor VIII - or Factor IX deficiency and von Willebrand disease have long been possible to diagnose, but with some difficulties for the latter. In the mid 1970's Antithrombin...
www.dia-service.se/        View full profile
Thumbshot

BioPortfolio Ltd. offers e-mail and postal lists for Antithrombin III scientists - we have details of around 918 individuals working on Antithrombin III .


This page has been viewed 385 times
Recent Search Terms used to find this page: pharmacokinetic profile of thrombate | antithrombin III mayo clinic | patent for Antithrombin III | antithrombin III companies | antithrombin III labor | antithrombin III | antithrombin III | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Antithrombin III across BioPortfolio, or for Antithrombin III Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.